KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biogen (BIIB) Goodwill (2016 - 2025)

Biogen has reported Goodwill over the past 17 years, most recently at $6.5 billion for Q4 2025.

  • Quarterly results put Goodwill at $6.5 billion for Q4 2025, changed 0.19% from a year ago — trailing twelve months through Dec 2025 was $6.5 billion (changed 0.19% YoY), and the annual figure for FY2025 was $6.5 billion, changed 0.19%.
  • Goodwill for Q4 2025 was $6.5 billion at Biogen, roughly flat from $6.5 billion in the prior quarter.
  • Over the last five years, Goodwill for BIIB hit a ceiling of $6.8 billion in Q3 2023 and a floor of $5.7 billion in Q3 2022.
  • Median Goodwill over the past 5 years was $6.0 billion (2021), compared with a mean of $6.1 billion.
  • Biggest five-year swings in Goodwill: rose 18.57% in 2023 and later decreased 4.73% in 2024.
  • Biogen's Goodwill stood at $5.8 billion in 2021, then dropped by 0.21% to $5.7 billion in 2022, then rose by 8.18% to $6.2 billion in 2023, then increased by 4.18% to $6.5 billion in 2024, then rose by 0.19% to $6.5 billion in 2025.
  • The last three reported values for Goodwill were $6.5 billion (Q4 2025), $6.5 billion (Q3 2025), and $6.5 billion (Q2 2025) per Business Quant data.